Vistapharm, founded in 1998 and now a part of Pai Pharma, is dedicated to being a trusted partner in the fight against substance use disorder and its associated stigma. Committed to upholding the highest ethical standards and regulatory compliance, Vistapharm offers a wide range of addiction treatment medications to support hospitals, retail outlets, acute care facilities, and substance abuse treatment centers.
With a focus on providing high-quality products, reliable supply, and exceptional customer service, Vistapharm strives to ensure an extraordinary customer experience. Their expansive product portfolio includes methadone, buprenorphine, buprenorphine and naloxone, and other pharmaceutical products, all aimed at addressing the challenges of substance abuse.
Generated from the website